ETHYL 3-(2,6-DICHLOROPHENYL)-5-CYCLOPROPYLISOXAZOLE-4-CARBOXYLATE, 95.0%, 1g

9,10-Dihydro-9,9-dimethylacridine>98.0%(GC)5g

Fmoc-D-3-Methylphenylalanine, 98%, 250mg

(S)-1-N-Benzyl-prolinol, 97.0%, 10g

p-(Octyloxyphenyl)phenyliodonium hexafluor antimonate, 25g

(R,E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide, 99.0%, 1g

N-(3-(Dimethylamino)propyl)methacrylamide, 95.0%, 500g

(R)-1-(4-Bromo-3-fluorophenyl)ethan-1-amine, 98%, 100mg

(S)-tert-Butyl 4-(4-(4-(2-amino-3-methoxy-3-oxopropyl)phenoxy)butyl)piperidine-1-carboxylate, 97%, 5g

Phenytoin Sodium>98.0%(T)500g

(4S,5R)-2-(6-Benzhydrylpyridin-2-yl)-4,5-diphenyl-4,5-dihydrooxazole, 97%, 1g

NBD-PZ (=4-Nitro-7-piperazino-2,1,3-benzoxadiazole) [for HPLC Labeling]>98.0%(HPLC)(T)100mg

Dowex® 50 W X 2, 250 g